FORTE BIOSCIENCES INC
FBRXNASDAQ🏆 #2061 by market capUS Equity
——
Quote unavailableTrack FBRX
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$1.63B
Small Cap
📈Revenue Growth (YoY)
-99.8%
Declining
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
40860.7x
Expensive
Otter Score
—
Insufficient data
No chart data available for FBRX.
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $10.30 – $77.20
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 21.2M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- —
- P/S Ratio
- 40860.7x
- EPS (TTM)
- $-4.60
- Dividend Yield
- —
- Dilution (1yr)
- +179.4%
FORTE BIOSCIENCES INC
FBRXFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$71M▲ +93.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$51M▲ +65.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
17.9M▲ +179.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$77M▲ +$55M YoY
StockOtter · stockotter.spaceAbout FORTE BIOSCIENCES INC
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.